Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Daryl C. Osbahr, M.D. to Lead Rothman Orthopaedics in Central Florida


News Image

Dr. Osbahr is one of the top sports medicine surgeons in Florida with a national reputation.

In September, Rothman Orthopaedic Institute announced their most recent expansion into Central Florida. This expansion will bring a full complement of fellowship trained, sub-specialized physicians under Rothman Orthopaedics – Florida. Today, Rothman Orthopaedics is excited to announce Daryl C. Osbahr, M.D. as Managing Director and Chief of Orthopaedic Surgery – Rothman Florida.

“Dr. Osbahr is one of the top sports medicine surgeons in Florida with a national reputation,” said Dr. Alexander R. Vaccaro, M.D., Ph.D., MBA, President of Rothman Orthopaedic Institute, Richard H. Rothman Professor and Chairman of the Department of Orthopaedics, and Professor of Neurosurgery at Thomas Jefferson University and Hospitals. “It was important to our brand that the leader selected for our Florida expansion had not only a national reputation of excellence but recognized in that same manner in the local market. We are thrilled to welcome him to the Rothman family.”

“Rothman Orthopaedics represents excellence in orthopaedic surgery and sports medicine,” said Dr. Osbahr. “I am thrilled to have an opportunity to help lead an initiative defined by excellence in all phases of orthopaedic surgery and sports medicine care, including the highest quality clinic care, education, research, innovation and sports team coverage.”

Dr. Osbahr completed his general surgery internship at New York-Presbyterian Hospital Weill Cornell Medicine and his orthopaedic surgery residency at Hospital for Special Surgery. He attended the American Sports Medicine Institute for his fellowship, where he learned under the tutelage of famed sports medicine surgeon, Dr. James Andrews.

He has worked in various roles in the professional, Olympic and amateur sports world, including chief medical officer and head orthopaedic surgeon for the Orlando City Soccer Club (MLS, NWSL USL and Development Academy); co-chief medical officer for USA Baseball; network team physician for US Soccer; team physician for the Washington Nationals, Atlanta Braves, and Washington Football Team; as well as orthopedic consultant for the WWE, PGA Tour, LPGA Tour and Baltimore Ravens.

Additionally, he has held high-level ranking positions in the field of sports medicine including Chair, AOSSM Stop Sports Injuries Committee; President, Florida Alliance for Sports Medicine; Executive Committee Member, Professional Soccer Physicians Society; Medical Task Force Member, National Women’s Soccer League; and Committee member, USA Baseball Medical & Safety Committee.

Dr. Osbahr is an adult and pediatric sports medicine surgeon who specializes in various conditions of the knee, shoulder & elbow including knee preservation and ligament reconstruction (ACL, PCL, and multiligament reconstruction, cartilage restoration, meniscus transplantation, osteotomy, etc.); complex shoulder surgery (baseball medicine, labral tears, latarjet procedure, rotator cuff repair, superior capsular reconstruction, etc.); and elbow reconstruction (baseball medicine, “Tommy John” surgery, cartilage restoration, etc.). He will begin seeing patients December 1, 2020 in Polk County, Florida.

More physician agreements will be announced in the next few weeks as Rothman will continue to build a roster of fellowship trained, sub-specialized physicians who have a history of exceeding clinical quality, reputation and share an interest in research and education. For more information, please visit RothmanFL.com.

About Rothman Orthopaedic Institute:

Rothman Orthopaedic Institute is a world-leader in the field of orthopaedics providing communities in Pennsylvania, New Jersey, New York and most recently in Florida through its new partnership with AdventHealth. Rothman Orthopaedics provides high-quality, compassionate and affordable musculoskeletal care that is grounded in evidence-based medicine—the results of which will exceed expectations.

Rothman Orthopaedic Institute orthopaedists treat patients at 38 office locations, three of which include orthopaedic urgent care clinics. Rothman also has surgical privileges at 58 facilities across the tristate region. With experts in nine orthopaedic sub-specialties including spine, hip and knee, foot and ankle, shoulder and elbow, hand and wrist, sports medicine, physical medicine and rehabilitation, orthopaedic oncology and trauma, Rothman Orthopaedic Institute is recognized for excellence in clinical treatment methods, research, education and technology.

Consistently recognized as national and regional “Top Docs,” Rothman Orthopaedic Institute is proud to be the official team physicians for the Philadelphia Eagles, Phillies, 76ers, the iconic Radio City Rockettes, The Big East Conference, as well as over 40 college and high school teams.

For more information about Rothman Orthopaedic Institute please call 1-800-321-9999 or visit http://www.RothmanOrtho.com.

Share article on social media or email:

Leading Doctors Announce Creation of Allied OMS, a Novel Private Equity Vehicle for Oral Surgeons


Allied OMS

Power Through Partnership

We sought to couple the clinical knowledge and decision making of respected oral surgeons with the business acumen of private equity veterans.

A group of prominent oral surgeons along with executives who have significant experience in private equity have announced the creation of Allied OMS. Fort Worth Oral Surgery, Evergreen Oral Surgery, and DuneGlass Capital have jointly created Allied OMS, a Management Services Organization (MSO) serving premier Oral and Maxillofacial Surgery (OMS) practices throughout the US. The MSO allows doctors to focus on patient care while reducing the burdens and complexities of running the day-to-day business.

“We have witnessed firsthand a persistent trend toward consolidation in healthcare. Solo practitioners, group practices, and dental service organizations (DSOs) have been partnering with private equity, fundamentally changing the practice of oral surgery. We sought to couple the clinical knowledge and decision making of respected oral surgeons with the business acumen of private equity veterans,” said Dr. Greg Scheideman, a partner at Fort Wort Oral Surgery and one of the founders of Allied OMS. “Our colleagues in dermatology and ophthalmology did not fully realize the value of their practices by prematurely divesting to other private equity groups, and it was not evident until years after the transaction.”

“We sought the advice of our oral surgery partners to engineer a radically different company, one that prioritizes building long-term value creation for our doctor partners and then sharing in that value creation,” said Dan Hosler, the CEO and co-founder of Allied OMS. “We are building a Doctor’s Private Equity company in the field of OMS.”

Allied OMS was launched at the height of uncertainty during the pandemic in April of 2020. Interest in this novel model has been overwhelming and they have given over 100 presentations to OMS practices nationwide. With Allied practices now in Texas and Colorado, Allied OMS anticipates announcing transactions with several respected practices in the coming months.

About Allied OMS

Allied OMS is a new generation of Management Services Organization. Allied OMS is collectively owned and governed by doctor members and founders, leveraging decades of private equity and management consulting experience to employ the tools that maximize practice value and to share these benefits with the doctors – they have turned Private Equity into Doctor EquityTM. Allied OMS is composed of best-in-class OMS practices that are in the top-tier of clinical outcomes. Contact Allied OMS at Partner@AlliedOMS.com to learn how they can help your practice be stronger by gaining Power Through PartnershipTM.

http://www.alliedoms.com    

About Fort Worth Oral Surgery

Fort Worth Oral Surgery (FWOS), led by Drs. Gregory Scheideman, William Runyon, Jr., and David Kostohryz, Jr., are known throughout the DFW area for their surgical skill and attentive patient care. With a particular focus on providing excellent patient outcomes, they offer a complete suite of oral and maxillofacial care.

http://www.fwos.com

About Evergreen Oral and Maxillofacial Surgery

Evergreen Oral and Maxillofacial Surgery of Evergreen, Colorado is home to Dr. Jundt, a highly regarded oral and maxillofacial surgeon. He has written an OMS textbook, patented and licensed products in OMS, and published over twenty-five peer reviewed articles in both national and international journals. Dr. Jundt enjoys spending time in Evergreen’s surgical suite and hospital operating rooms covering a wide variety of case complexity.

http://www.evergreenoms.com

About DuneGlass Capital

DuneGlass Capital was founded to help healthcare companies realize their full potential. With a combined three decades of experience including multi-unit operations, private equity deal structuring, and healthcare business strategy, the founders of DuneGlass have created a repeatable process for value creation. As sons of physicians, they understand how important it is to mentor their clinical shareholders in private equity to maximize the intrinsic value of the practices. Contact DuneGlass Capital at Partner@duneglasscapital.com to learn more about how we can enhance the value of your practice.

http://www.duneglasscapital.com

Share article on social media or email:

Re-envisioning Life Sciences Through the FHIR Gateway, Upcoming Webinar Hosted by Xtalks


With FHIR being accepted and implemented across the healthcare domain it will solve a major hurdle of security and confidentiality of PHI and CCI.

Patient records are currently stored in disparate systems (care, pharmacy, lab) in varied clinical settings (hospital, primary care, community services), and in different formats (data models, structured vs. unstructured data) governed by different regulatory and privacy policies. There is a rise in the volume of source data such as genomics and self-monitoring devices data as technology becomes affordable and more prevalent.

The need of the hour is availability of structured and standardized data that can be easily integrated into research databases to support collection and verification of clinical study data, automated research work flow, accelerated data analysis, clinical decision support and other machine-based processes. HL7 FHIR continues its strong trajectory of global adoption across the healthcare industry because of its ability to provide a common, API standards-based window into disparate systems to provide a common platform for applications-based data access, sharing and reuse.

FHIR going forward will become an integral part of life sciences data exchange, as it is customizable and vendor neutral, thus paving way to a revolution in life sciences industry. With FHIR being accepted and implemented across the healthcare domain it will solve a major hurdle of security and confidentiality of PHI and CCI.

Join Shreejit Nair, SVP & Business Lead, Life Sciences Market, CitiusTech, Wayne Kubick, Chief Technology Officer, Health Level Seven International and Dr. W. Ed Hammond, PhD, Director, Duke Center for Health Informatics Duke Clinical & Translational Science Institute in a live webinar on Thursday, October 22, 2020 at 1pm EDT.

For more information or to register for this event, visit Re-envisioning Life Sciences Through the FHIR Gateway.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Compliancy Group restructures their implementation department and streamlines their HIPAA compliance process


“We are dedicated to customer service and simplified compliance. Clients asked us for a compliance process that was quicker and easier to complete, and we were happy to provide it for them.”

Compliancy Group has restructured its implementation process and department to further simplify the process of earning a Seal of Compliance, and increase customer satisfaction.

The new structure:

Director of Implementation: Charlotte Barenz, CHP, is now the Director of Implementation. Charlotte is Compliancy Group’s most seasoned Compliance Coach with several years experience in the healthcare space, and a long time Compliance Coach. In her new role, Charlotte is responsible for overseeing the implementation team.

Compliance Coaches: will continue to be dedicated to guiding new clients through achieving and illustrating their HIPAA compliance.

Customer Success Coaches: will guide existing clients through maintaining their HIPAA compliance by assisting them with annual audits. Schedule your annual review!

Support: to better serve clients a new support ticketing system has been deployed. The new system answers clients’ questions and allows one point of contact for all support needs email support@compliancygroup.com

Compliancy Group has also streamlined its proven proprietary methodology, Achieve, Illustrate, Maintain™, enabling clients to become HIPAA compliant in as little as 3 simple meetings. The new documentation, training videos, and restructured process reduces client meetings, and allows clients to implement an effective HIPAA compliance program in 60% less time.

“We are dedicated to customer service and simplified compliance. Clients asked us for a compliance process that was quicker and easier to complete, and we were happy to provide it for them. Our new process delivers the same verification and validation of a client’s efforts, while providing the same ‘No client has ever failed an audit confidence,” Marc Haskelson, CEO and President, Compliancy Group.

Changes include:

New policies and procedures

Streamlined self-audits

Engaging training videos

Seal of Compliance package

Documentation and training in Spanish

State level regulations – Texas HB 300

OSHA compliance

Compliancy Group Resources:

Get Your Seal of Compliance

HIPAA Compliance Checklist

HIPAA Webinars

About Compliancy Group:

Compliance should be simple. That’s why Compliancy Group is the only HIPAA and OSHA software with expert Compliance Coaches™ holding your hand to simplify compliance. Listed on Inc. 2020 Best Places to Work and 2020 Inc. 5000 list of the fastest-growing private companies in America, you can be confident that you will receive the best possible customer service. Having dedicated employees that care about their work means that they care about your success. Compliancy Group gives you peace of mind in your compliance plan reducing risk, increasing patient loyalty, and profitability of your organization.

Visit http://www.compliancy-group.com or call 855.854.4722 to learn how simple compliance can be.

Share article on social media or email:

The Dentists Supply Company and Henry Schein Inc. form new entity to better serve members of organized dentistry


News Image

“We’re excited to join Henry Schein, as it will expand TDSC’s value proposition to our members.” -Walt Weber, DDS, chair of TDSC’s Board of Directors

The Dentists Supply Company is pleased to announce it has reached an agreement with Henry Schein Inc. (Nasdaq: HSIC) to further its mission to serve state dental association members with an online-only option for purchasing dental supplies. TDSC.com, Powered by Henry Schein will officially launch in late October 2020 and will continue to offer everyday low pricing and expand its offerings for dental supplies and small equipment to dental association members.

Launched in 2017 by the California Dental Association (CDA), TDSC serves members of all 50 state dental associations with an everyday low-price, online-only option for obtaining dental supplies. Any member of a state dental association is eligible to purchase on TDSC.com. While TDSC enjoyed a strong growth trajectory, the COVID-19 pandemic presented an opportunity to evaluate strategic options for providing greater value to its members.

“We’re proud of TDSC’s growth since its inception to help members of organized dentistry remain competitive in a challenging practice environment,” said Walt Weber, DDS, chair of TDSC’s Board of Directors. “We’re excited to join Henry Schein, as it will expand TDSC’s value proposition to our members.”

As the world’s leading provider of health care solutions to office-based dental and medical practitioners, Henry Schein’s expertise will enable TDSC to build on its already strong model with improved fulfillment rates and delivery times, among other distribution and operational efficiencies.

Henry Schein will be the majority owner with CDA owning an interest in the newly formed operating company TDSC Inc. The new company will also form an advisory council, which will include key stakeholders from both organizations, dental association leaders and practicing dentists to provide insights and guidance to the operating team along with its board of directors. Financial terms were not disclosed.

“We are most enthusiastic to partner with TDSC, a company that shares Henry Schein’s commitment to helping dental practices operate more efficiently so practitioners can focus on the quality of care delivered,” said Stanley M. Bergman, chairman of the board and chief executive officer of Henry Schein. “Our two organizations are well-aligned in our key values, including supporting the dental profession and the next generation of dentists, as well as promoting the connection between oral health and overall health. Henry Schein’s full-service distribution model, coupled with TDSC’s strategy, will offer dental association members the options the profession seeks when choosing to purchase dental supplies and small equipment for their practices. We look forward to welcoming our new colleagues from TDSC to Team Schein.”

The channels offered by TDSC and Henry Schein are complementary and aimed at delivering service models for varying customer segments. Dentists purchasing supplies through TDSC.com will continue to enjoy the convenience of online ordering and everyday low pricing and will now also benefit from an expanded product portfolio and faster delivery service. Henry Schein will maintain its full-service distribution model offering customers competitively priced consumable merchandise, equipment and technology products and services, including software, coupled with its highly experienced field and telesales teams. Henry Schein also plans to offer a select set of branded consumable merchandise as well as Henry Schein corporate brand products to TDSC customers.

“We remain steadfast in our commitment to offer a full-service model — as the main component of our dental strategy — that delivers the solutions customers can rely on to operate a more profitable practice and better serve their patients,” said AJ Caffentzis, president, U.S. Dental Distribution, Henry Schein Dental. “We recognize that there are some members of organized dentistry who want an alternative channel for purchasing dental supplies and we look forward to meeting their needs. We also look forward to welcoming new customers and providing all customers of TDSC.com with the option to expand our relationship through our full-service model.”

About The Dentists Supply Company

The Dentists Supply Company (TDSC) leverages collective purchasing power to attain better supply pricing for practices of every size. Founded as a subsidiary of the California Dental Association, TDSC provides significant savings on dental supplies from authorized vendors as a benefit included in dental association membership. The Company’s 2019 sales were approximately $20 million. For more information, visit http://www.tdsc.com.

About Henry Schein Inc.

Henry Schein Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 19,000 Team Schein Members worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 value solutions that improve operational success and clinical outcomes. Its Business, Clinical, Technology and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® Index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 31 countries. The Company’s sales from continuing operations reached $10 billion in 2019 and have grown at a compound annual rate of approximately 13% since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at http://www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.

Share article on social media or email:

The Trends Defining Healthcare’s Next Normal & the Hospital Financial Model They Require – Industry Analysis by Loyale Healthcare


COVID-19 has accelerated healthcare innovation with long-term impacts on patients and their pocketbooks.

Automating patient financial interactions at scale improves patient experiences and radically reduces costs. At the same time, its enthusiastic acceptance by patients improves hospital competitiveness and the opportunity for market share growth. – Kevin Fleming, CEO, Loyale Healthcare

To be sure, healthcare is and should be credited for its remarkable adaptability in the wake of the COVID-19 crisis. Well before the national emergency was proclaimed, hospitals and other providers began working to shore up capacity and overcome the scarcity of personal protective equipment (PPE). More than that, though, healthcare exhibited the kind of rapid innovation that was all too rare across the industry before the crisis.

Given the success of innovations like the ramp-up of telehealth and the extreme stress placed on healthcare providers and their patients since the crisis began, it’s easy to understand why so many are speculating about the future of the industry. But regardless of the source, the clear consensus among industry experts and watchers is that healthcare will emerge from this crisis with a mandate for continued transformation.

McKinsey & Company explored the speed of the industry’s response to the crisis in analysis published just last week titled, “The great acceleration in healthcare: Six trends to heed.” In it, the global consulting firm calls out previous analysis stating, “The fault lines between industries and business models that we understood intellectually before the crisis have now become giant fissures, separating the old reality from the new one.” Addressing the difference between old and new, the article’s introduction concludes that, “As US healthcare leaders set the direction for their organizations, six trends stand out.”

Those six trends are:

1.    Reform

2.    Health for all

3.    Era of exponential improvement unleashed

4.    The big squeeze

5.    Fragmented, integrated, consolidated care delivery, and

6.    Next generation managed care accelerated.

The analysis goes on to elaborate on the six trends from a macro level, but we’re drilling down into the hospital operating function that we are proficient in, revenue cycle – or more specifically – patient revenue cycle.

Reform

In the area of reform, the McKinsey analysis frames healthcare’s potential “along three dimensions: COVID-19-era waivers that could become permanent; actions that may be taken to strengthen the healthcare system to deal with pandemics; and reforms to address the COVID-19-induced crisis.” Noting that “the crisis has revealed areas that could improve the resilience of the system,” it goes on to list opportunities to control future viral spreads and improve resilience (e.g. supply chain and the ability to “flex up critical care capacity and clinical workforce”). The section on reform concludes by calling attention to the economic impact of COVID-19, noting “historic economic pressures across federal and state governments, corporations, and American households.”

This kind of economic dislocation, the analysis notes, “has often been followed by major healthcare reform.” The analysis’ report that as many as “10 million Americans may lose employer-sponsored healthcare coverage by the end of 2021” underscores a growing economic phenomenon we have pointed out before. In an article published this summer titled, “Healthcare Affordability is More Than a Problem. It’s a Crisis” we cited research confirming that Americans were struggling to pay their portion of healthcare bills long before the COVID crisis began. The coronavirus is making it worse.

In the article, we explored aggressive regulatory pressure from the U.S. Dept. of Health and Human Services (HHS) and its agency, The Center for Medicare and Medicaid Services (CMS) to improve price transparency and eliminate surprise medical bills among other objectives. This pressure has not abated during the crisis and the economic conditions created by the crisis will only deepen the will of regulators and legislators to do more. The choice for providers is whether to merely comply with regulatory requirements, or to get ahead of the curve by embracing technology, like Loyale’s Patient Financial Manager, engineered to reduce the financial barriers to patient care.

Health for All

The second trend, Health for all, notes that the pandemic “has amplified existing inequitable health outcomes (along) five intersecting health and social conditions…correlated with poorer health outcomes.” These include physical health (those with chronic conditions, the immune-compromised); behavioral health challenges (“individuals at an increased risk of developing severe COVID-19 symptoms are nearly twice as likely to have a behavioral health condition”); Unmet social needs (food or housing insecurity, high unemployment); racial inequity and access to care, including mental health care.

For patients and prospective patients who fall into one or more of these five areas, affordability often imposes a barrier to healthcare. In Research published by the Kaiser Family Foundation “thirty four percent of insured adults say it is either “very difficult” or “somewhat difficult” for them to afford to pay their deductible. Other research reports that as many as half of Americans are avoiding or delaying care because they don’t think they can afford their out-of-pocket. Again, clearly, the issue of “health for all” is directly affected by the affordability of care. Hospital policies should be adjusted, as they are in nearly every other industrial sector, to bring the purchase price of their service within reach.

The Era of Exponential Improvement Unleashed

Trend number 3, the “Era of exponential improvement unleashed” addresses healthcare’s COVID-inspired investments in technology to overcome operational challenges and radically improve operating efficiency. The McKinsey & Company analysis reports “that health systems, primary care and behavioral health practices are reporting increases of more than 50-175 times in telehealth visits, and the potential market size for virtual care could reach around $250 billion.” Telehealth and other virtual care delivery channels, with their inherently clinical focus, however, represent an incomplete solution to patients’ real requirements.

Recently, we published analysis titled, “Patients Love Virtual Health. Digital Financial Engagement Makes it Better.” In it, we pointed out that “To achieve a truly patient centric experience, hospitals and health systems must expand their vision for virtual care to include every patient experience in every setting.” Pointing out the financial obstacles to care – even virtual care – the analysis envisions the integration of technology to “reliably present non-emergent patients with price estimates that include their projected out-of-pocket…so patients can make informed judgments about whether and where to seek care.” As mentioned above, this integrated technology also provides for provider – patient interactions to improve affordability.

The Big Squeeze

The fourth trend – The big squeeze – studies the immense pressure on healthcare revenues because of the crisis, and the lasting economic challenges attributable to reduced state tax levels (Medicaid), a higher percentage of uninsured patients and possible coverage reductions by employers. The McKinsey analysis “estimate(s) that COVID-19 could depress healthcare industry earnings by between $35 billion and $75 billion compared with baseline expectations.” At the same time, however, it estimates that “between $280 billion and $550 billion in opportunity within healthcare delivery by 2028 achievable through productivity gains.”

We studied this opportunity in analysis titled, “Five Critical Operational and Financial Capabilities Required for Healthcare’s Financial Survival.” These included: 1) Contactless patient financial engagement, 2) Patient population segmentation, 3) Scalable, personalized omni-channel communications, 4) Affordability options (like those described above), and 5) end-to-end patient payment analytics. Critically, all the work associated with these technologies is conducted digitally. Providers that employ these systems can reduce operating costs by tens of millions or more, depending on their size.

Fragmented, Integrated, Consolidated Care Delivery

Trend number five – “Fragmented, integrated, consolidated care delivery,” explores the “shift of care out of hospitals,” pointing out that “Care in the next normal could be increasingly delivered in distributed sites of care, integrated around the patient through digital and analytics across patient-centered ecosystems.” Here, of course, the operative concept is the notion of technology-enabled patient centricity, which our experiences have proven can have profound financial implications for providers of all kinds.

For example, the Loyale Patient Financial Manager™ technology platform seamlessly integrates the patient’s financial experiences across complex care delivery networks, following the patient to every setting throughout the course of treatment. It then consolidates multiple bills into one single bill which is then presented digitally, where it can either be paid in full or included in the patient’s new or existing payment plan.

Next Generation Managed Care Accelerated

The sixth and final trend, “Next generation managed care accelerated”, focuses on payers (health insurance companies), the changing economics of shifting costs to already overburdened employees, and the better financial performance achieved by payers that integrate more deeply with care delivery. Calling on the industry to consider restructuring, it references Medicare Advantage and its more active influence on patient treatment.

From a hospital and health system financial perspective, we view managed care as another threat to revenue. However, as with the other revenue pressures described above, the challenge can be overcome through improved efficiencies and higher revenues. Platform-enabled patient financial engagement offers a path toward both. Automating patient financial interactions at scale improves patient experiences and radically reduces costs. At the same time, enthusiastic acceptance by patients improves hospital competitiveness and the opportunity for market share growth.

At Loyale, we’re optimistic about the future of health systems and hospitals. COVID-19 has stimulated game-changing innovation and organizational resilience that have already set the stage for healthcare’s next and greatest act. We’re proud to be a part of that transformation.

Kevin Fleming is the CEO of Loyale Healthcare.

About Loyale

Loyale Patient Financial Manager™ is a comprehensive patient financial engagement technology platform leveraging a suite of configurable solution components including predictive analytics, intelligent workflows, multiple patient financing vehicles, communications, payments, digital front doors and other key capabilities.

Loyale Healthcare is committed to a mission of turning patient responsibility into lasting loyalty for its healthcare provider customers. Based in Lafayette, California, Loyale and its leadership team bring 27 years of expertise delivering leading financial engagement solutions for complex business environments. Loyale currently serves approximately 12,000 healthcare providers across 48 states. Loyale is proud to have an enterprise-level strategic partnership with Parallon which includes the deployment of Loyale’s industry leading technology at all HCA hospitals and Physician Groups.

BlueCloud and VirTrial collaborate to launch the first global training and certification program for telemedicine best practices.


News Image

BlueCloud® by HealthCarePoint (HCP) and VirTrial today announced a global collaboration that will enable international investigator sites to become VirTrial technology competent and ready for the benefit of Sponsors, CROs, Universities, regulatory agencies and other industry stakeholders, and ultimately patients.

The training and certification initiative aims to provide sustainable study and patient opportunities for investigator sites, while demonstrating telemedicine technology competencies in the eyes of international regulators.

VirTrial developed the program, using BlueCloud standards, while BlueCloud will provide its global networking infrastructure to Deliver, Distribute, Implement and Track (DDIT™) training competencies and certifications for business and compliance purposes.

“We’ll be inviting our global network of healthcare professionals from investigator sites to participate in this modern initiative to help sites improve long term sustainability in this current and future environment,” said Al Pacino, President and co-founder of BlueCloud by HealthCarePoint. “Just as hundreds of training and certification programs in our network currently use to minimize data variance in clinical trials, our healthcare and clinical research members will benefit by dynamically sharing their global certifications 24/7 with Sponsors, CROs, Universities and other industry stakeholders using their personal and private GDPRWallet®, for any current and future decentralized clinical trials. Verifiable and accessible in real-time, Investigator sites will also benefit by having employer’s VirTrial certifications as part of their dynamic research ready auditable (HR) GDPRDirectory® commonly used for business and compliance tracking, all from one place.”

“VirTrial was created with sites in mind from the start,” says Kim Kundert, Executive Vice President. “The very concept of clinical research sites is embedded in our founding team’s DNA, so we understand what it’s like to try and keep up with all of the technological changes associated with virtual trials. That’s why we provide our Virtual Trial Capable training for sites.”

About BlueCloud®

As a global standards delivery network and as the inventors of the GDPRWallet® and GDPRDirectory®, BlueCloud enables healthcare and clinical research sites to be connected with sponsors, CRO’s, universities and thousands of other industry stakeholders for marketing, business and compliance purposes. Available in more than 169 countries and used by close to 2 million healthcare professionals, BlueCloud systems are used by members to connect, organize, centralize and share real-time verifiable information for marketing, managerial and compliance activities. Internationally, BlueCloud creates a real-time global network that is proven to save the industry millions of dollars by eliminating redundancies, expediting study start up, and ensuring quality, transparency and compliance, with the ultimate goal to modernize the ecosystem through real-time, live connectivity. BlueCloud is the sustainable system that “leaves no patient behind®” regardless of religion, race, geography or socio-economic status.

About VirTrial

“VirTrial’s platform enables pharmaceutical companies and CROs to empower their selected clinical research sites to perform virtual visits – a combination of secure video, audio, chat and messaging, which can be used on any device. Incorporating VirTrial’s virtual visits into study protocols opens the door to a wider participant pool, ultimately yielding improved study outcomes and efficient site performance.

Unlike other clinical trial vendors that began as technology companies, VirTrial has a stable of clinical research veterans and experienced tech entrepreneurs teaming together to lead the company towards providing the human population with remote access to clinical research sites.

To learn more about VirTrial, visit https://www.virtrial.com

Share article on social media or email:

EGYM Expert Series – Boutique Fitness Today And Tomorrow


News Image

“Despite the impact of COVID, the future of boutique experiences looks bright and I expect to see even more interesting combinations of service offerings in including the delivery of more health and wellbeing focused concepts addressing the BOOMERLENIAL marketplace. ”

EGYM, a global fitness technology leader providing fitness and health facilities with intelligent hardware and mobile application solutions, announced the next edition of their live expert series: Boutique Fitness Today and Tomorrow on October 20, 2020, 12:00 PM Mountain/ 2:00 PM Eastern Time (U.S. and Canada).

Boutique fitness studios and experiences exploded in the past decade.

Whether taking a yoga class or saddling up on the front row for a cycling class, over the past decade this major shift impacted the global fitness industry by creating a diverse landscape of disruptive new boutique studio entrants.

This shift was being driven by various Mega-trends reflected in most consumer-facing industries: a bifurcation of market offerings including more premium and low-cost options, the unbundling of membership dues with the offering of more fitness experiences delivered via specialized providers, and the continued rise of the experience economy with components of convenient technologies integrated within.

EGYM, in collaboration with Fitness Industry Technology Council, invites all professionals and stakeholders in the health club, gym, boutique fitness space, to conversation on recent trends regarding boutique fitness and what is expected in the future with one of the world-class experts on the subject; Emma Barry.

Topics will include:

1. What led to the Boutique Fitness Trend In the First Place?

2. What has happened to Boutiques as a result of COVID?

3. What do we see for Boutiques in the coming years and Why?

Panelists will include:

  • Emma Barry (Keynote Speaker, Author, Advisor, and CMO of Good Soul Hunting)
  • Dana Milkie (Vice President of Digital for EGYM North America)
  • Bryan O’Rourke (CEO of FITC | Vedere Ventures)

Bryan O’Rourke, CEO of FIT-C and Vedere Ventures, who is a thought leader in technology and trends in the health and fitness industry shared his thoughts on the series, “Boutiques have been a global phenomenon in the fitness industry for the past decade. Despite the impact of COVID, the future of boutique experiences looks bright and I expect to see even more interesting combinations of service offerings in including the delivery of more health and wellbeing focused concepts addressing the BOOMERLENIAL marketplace. ”

For registration and more information, please follow the link to Register Here.

# # #

About EGYM

EGYM is a global fitness technology leader providing fitness and health facilities with intelligent workout solutions. EGYM makes exercising smarter and more efficient with its comprehensive suite of connected gym equipment and digital products that integrate seamlessly with 3rd-party hard- and software. The result is a fully connected training experience that drives measurable business and health outcomes on and off the training floor.

EGYM’s global headquarters are in Munich, Germany, with North American offices in Boulder, Colorado.

https://egym.com

About The Fitness Industry Technology Council

The Fitness Industry Technology Council is a not for profit consortium of leading professionals and organizations representing the fitness industry. The council seeks to grow the fitness industry, improve fitness user experience through thoughtful adoption of technologies, and mature the collection of real-time wellness data through the creation of interoperability standards.

FITC’s headquarters are located in the New Orleans, Louisiana area.

http://www.fittechcouncil.org/

About Emma Barry

Emma has served in key leadership roles in the fitness industry including Director of Group Fitness for Equinox and as a founder for group fitness exercise for Les Mills International. As an author, speaker, and advisor, Emma is considered one of the leading thinkers in the health club, gym, and boutique fitness space. She has advised global fitness brands around the world on various aspects of concept development, customer experience, and more. Her book Building a Badass Boutique: Your 10-Touch Journey to Designing a Fitness Studio That Rocks is available on Amazon has been received with rave reviews. She recently joined Good Soul Hunting, a boutique talent agency, where she serves as Chief Creative Soul.

Emma Barry is based in the Los Angeles area.

https://www.facebook.com/emmaccbarry/

Share article on social media or email:

NDA Partners Expert Consultant, Elizabeth T. Martin, MD, Receives 2020 CAP Advocate of the Year Award


News Image

I am honored to receive this award for my contributions to CAP’s advocacy efforts and for my long-term commitment to representing pathologists and the field of pathology and laboratory medicine.

NDA Partners Chief Executive Officer Earle Martin announced today that Dr. Elizabeth T. Martin, one of the firm’s prominent Expert Consultants, was recently honored by the College of American Pathologists with the 2020 CAP Advocate of the Year Award. Dr. Martin was recognized for her personal engagement in advocacy and dedication to the pathology profession through her demonstrated long-term commitment to representing pathologists through regular contributions to CAP’s PathPAC and through her advocacy efforts to local lawmakers on health care policy.

Dr. Martin is a Board-certified Pathologist with specialized expertise in GI and infectious disease pathology. She currently serves as CLIA Medical Director in the Fairfax County, Virginia Health Department Laboratory and as a Pathologist in several hospitals and independent laboratories in Virginia and Maryland. She was formerly the Medical Director of the Recovery for Life Laboratory, Medical Director of the Tri-State Medical Specialists Laboratory, and Acting Director of Pathology at Holy Cross Hospital in Maryland. She has also served as Assistant Director of the Microbiology Laboratory at the New England Medical Center in Boston and as a local Medical Examiner for the Commonwealth of Virginia. In addition, she was an Assistant Professor of Pathology at Tufts University School of Medicine in Boston. Most recently, she joined NDA Partners as an Expert Consultant to support clients developing diagnostic and pathology imaging products, obtaining CLIA certification and CAP accreditation, and establishing lab information systems.

“I am honored to receive this award for my contributions to CAP’s advocacy efforts and for my long-term commitment to representing pathologists and the field of pathology and laboratory medicine,” said Dr. Martin.

Dr. Martin received her medical degree from The University of Virginia and bachelor’s degree from the College of William and Mary in Williamsburg, Virginia. She completed a residency in anatomic and clinical pathology at the New England Medical Center in Boston, a residency and internship in general surgery at the Hartford Hospital in Connecticut, and a residency in pathology at the Lovelace – Bataan Medical Center in Albuquerque.

About NDA Partners

NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.

Contact

Earle Martin, Chief Executive Officer

Office: 540-738-2550

MartinEarle@ndapartners.com

Share article on social media or email:

Top Montana Infectious Disease Doctor Publishes Coronavirus Book; Dr. David Graham’s ‘From Killer to Common Cold’ Walks Readers Through Basics of What’s Next for Covid-19


Author and Infectious Disease Doctor David Graham publishes book: ‘From Killer to Common Cold’

Too often, people don’t tell you what to expect from Covid-19. What is next? Where do we go from here? What if we start by understanding what a virus wants and finish by understanding the end-game of Covid-19: it will become another common cold coronavirus.

“Too often, people don’t tell you what to expect from Covid-19. What is next? Where do we go from here? What if we start by understanding what a virus wants and finish by understanding the end-game of Covid-19: it will become another common cold coronavirus,” says Author and Infectious Disease Doctor David Graham. “I predict it will be two to five years before the transitional phase ends and Covid-19 is merely a cause of the common cold.”

Dr. David Graham is a practicing board certified infectious diseases physician in Billings, Montana. He’s also a Covid-19 business consultant and expert witness, a retirement planner for physicians, a financial and medical blogger at FiPhysician, a published author, a husband and a father of three young kids. His book, From Killer to Common Cold: Herd Protection and the Transitional Phase of Covid-19 launched worldwide October, 2020 and is available in paperback and eBook versions via Amazon Prime. The eBook version is also available via Barnes & Noble for Nook and Kobo.

Throughout the short, 111-page book, Dr. Graham outlines his theory on the destiny of SARS-CoV-2 in an easy-to-understand way.

“I believe that the destiny of SARS-CoV-2 is already written. With or without a vaccine, with or without an effective treatment, with or without expected technological advances, we are destined to interact with this virus forever. SARS-CoV-2 is not eradicable and will become endemic,” says Dr. Graham. ”There are already four coronaviruses that are endemic and cause the common cold. SARS-CoV-2 will become the fifth endemic human coronavirus. The virus that causes COVID-19 will become another common cold.”

The book also discusses herd immunity vs. herd protection and allows the reader to understand the many factors in their community that affect the timeline of the virus reaching its end-game and transitioning into a common cold.

“This virus has changed the world. It’s made it difficult to visualize our life and our travel plans over the next several years,” says stay at home mom + lifestyle TV host Dianne Parker. “Dr. Graham’s book has given us a different view to consider. It has helped our family put everything into perspective. As a huge bonus, I get to be the smart mom who teaches my kids a lesson about how viruses work.”

“From Killer to Common Cold is a wonderful read. It is honest and refreshing. It answers a lot of my questions. I’ve found that health experts have been afraid at times to deliver the honest goods on the virus, vaccines and the pandemic in general. Dr. Graham’s book also gives us hope that we can and will get ‘to the other side’,” says Dale Roberts, an advocate for low fee index investing.

“The question on everyone’s mind right now is how and when does this end? As for when, Dr. Graham suggests it will be two to five years before things return to a pre-pandemic level of activity. But even then perhaps life will seem very different and foreign to us today, (but) when it comes to humanity versus the virus, Dr. Graham suggests we lay our money down on humanity overcoming this new obstacle and flourishing again,” says Anesthesiologist and host of The Paradocs Podcast Dr. Eric Larson.

“Dr. Graham’s infectious disease expertise paired with his ability to explain complex medical information to the average reader shines in this book. It’s a phenomenal read and I highly recommend this,” says Billings, Montana Physician Dr. Tom James.

More information and excerpts from the book are available at http://www.fiphysician.com. Visual content, including downloadable videos, photos and graphics, are available here.

Share article on social media or email: